Cyclopropyl derivative lipoxygenase inhibitors
US5120752A · kind A · utility
9Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 1990 |
| Grant date | Jun 9, 1992 |
| Priority date | — |
| Expiry date | Dec 6, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Certain carbocyclic aryl- and heterocyclic aryl- substituted cyclopropyl N-hydroxyureas, N-hydroxy-carboxamides, and N-acyl-N-hydroxyamines inhibit 5- and/or 12-lipoxygenase and are useful in the treatment of inflammatory disease states.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.